SparingVision
FranceEntry
2020
Hold
6yr
Status
Active
Who owns SparingVision?
SparingVision is a French Biotech company, currently owned by Ysios Capital Partners since 2022 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
4Bio Partners4BIO Ventures III · 2022 · Life Sciences VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by AdBio Partners, Jeito Capital, 4Bio Partners and Ysios Capital Partners since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
AdBio PartnersActive
2019 · present(7yr) · AFB Seed-Fund · 2017 · VC
4Bio PartnersActive
2020 · present(6yr) · 4BIO Ventures III · 2022 · Life Sciences VC
Jeito CapitalActive
2020 · present(6yr) · Jeito I · 2021 · VC
Ysios Capital PartnersActive
2022 · present(4yr) · Ysios BioFund III · 2020 · Life Sciences VC
More from 4BIO Ventures III
Other portfolio companies in the same fund.
Italy
United States
UK
Switzerland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns SparingVision?
SparingVision is currently owned by Ysios Capital Partners, Jeito Capital and 2 others, through 4BIO Ventures III, since 2022.
When did Ysios Capital Partners and 3 others acquire SparingVision?
Ysios Capital Partners and 3 others acquired SparingVision in 2022.
Who has owned SparingVision over time?
SparingVision has been through 4 private-equity ownership periods: AdBio Partners · via AFB Seed-Fund · since 2019; Jeito Capital · via Jeito I · since 2020; 4Bio Partners · via 4BIO Ventures III · since 2020; Ysios Capital Partners · via Ysios BioFund III · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue